The International Tennis Integrity Agency (ITIA) has confirmed that Gilbert Soares Klier Junior, a 22-year-old Brazilian tennis player, has been provisionally suspended under Article 7.12.1 of the 2022 Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 9 June under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample) and Article 2.2 (Use of a Prohibited Substance without a valid TUE), confirming they were provisionally suspended from that date.
Klier Junior, who has an ATP ranking of 367, provided a sample whilst competing at an ATP Challenger tournament in Mexico City in April 2022. That sample was split into A and B samples and the subsequent analysis found that the A sample contained SARM S-22, which is a non-specified prohibited substance listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytical Findings for non-specified substances carry a mandatory provisional suspension.
The player exercised their right to request that the B sample was analysed, which confirmed the finding in the A sample. While provisionally suspended, the player is ineligible to compete in or attend any tennis events authorised, organised or sanctioned by the governing bodies of the sport.
The ITIA is the delegated third party, under the World Anti-Doping Code of the International Tennis Federation, the international governing body for the sport of tennis and signatory of the Code. The ITIA is responsible for the management and administration of anti-doping across professional tennis in accordance with the 2022 TADP.
Ends
Published 24 June 2022 16:30
